BiotechTube
Home/Synklino/Thomas Kledal
TK

Thomas Kledal

CEO & Co-founder

Synklino

Therapeutic Areas

Infectious DiseasesTransplantation

Synklino Pipeline

DrugIndicationPhase
SYN002Prevention of Cytomegalovirus (CMV) infection in transplant recipientsPre-clinical

Leadership Team at Synklino

JW
Jette Wagtberg Sen
COO
View full Synklino profile